BioWisdom in J&J renewal - News - Life Sciences - Business Weekly

HOME

BioWisdom in J&J renewal

Written by News Desk
Wednesday, 12 March 2008
Healthcare giant, Johnson & Johnson Pharmaceutical Research & Development (J&J PRD), has renewed its collaboration agreement with BioWisdom’s OmniViz for the license rights to the information visualisation and data mining OmniViz software. “As our investment in the creation of truly ontology powered applications like OmniViz grows, so does the importance of our strategic collaborators with real world use cases and validation,” said Michael Stapleton, BioWisdom’s chief business officer. Set as favorite Bookmark Email This Hits: 257 Trackback(0) TrackBack URI for this entry Comments (0) Subscribe to this comment's feed Show/Hide comments Write comment Show/Hide comment form This content has been locked. You can no longer post any comment.